These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 16212)

  • 41. Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fibrosis.
    Boyle BJ; Long WB; Balistreri WF; Widzer SJ; Huang N
    Gastroenterology; 1980 May; 78(5 Pt 1):950-3. PubMed ID: 7380201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical pharmacology for pediatricians. I. Pancreatic enzyme preparations, with special reference to enterically coated microspheres of pancrelipase.
    Cho YW; Aviado DM
    J Clin Pharmacol; 1981; 21(5-6):224-37. PubMed ID: 7021605
    [No Abstract]   [Full Text] [Related]  

  • 43. [Investigations of the lipase activity of a pancreatin compound (author's transl)].
    Preisich P
    Med Klin; 1976 May; 71(19):820-4. PubMed ID: 5651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increase in urinary indican excretion in pancreatic steatorrhoea following replacement therapy.
    Miloszewski K; Kelleher J; Walker BE; Davies T; Smith CL; Losowsky MS
    Scand J Gastroenterol; 1975; 10(5):481-5. PubMed ID: 1153945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of dose-response with Pancrease MT for the treatment of exocrine pancreatic insufficiency in adults.
    Opekun AR; Sutton FM; Graham DY
    Aliment Pharmacol Ther; 1997 Oct; 11(5):981-6. PubMed ID: 9354210
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy].
    Löser C; Fölsch UR
    Leber Magen Darm; 1991 Mar; 21(2):56, 59-62, 65. PubMed ID: 1710011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Study of the gastrointestinal bioavailability of a pancreatic extract product (Zenpep) in chronic pancreatitis patients with exocrine pancreatic insufficiency.
    Lieb JG; Patel D; Karnik N; Toskes PP
    Pancreatology; 2020 Sep; 20(6):1092-1102. PubMed ID: 32800653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of maldigestion associated with pancreatic insufficiency.
    Perry RS; Gallagher J
    Clin Pharm; 1985; 4(2):161-9. PubMed ID: 3987214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of two forms of enteric-coated pancrelipase In six teenagers with cystic fibrosis.
    Warwick WJ; Budd JR
    Clin Ther; 1982; 5(1):15-20. PubMed ID: 7127365
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative trial of viokase, pancreatin and Pancrease pancrelipase (enteric coated beads) in the treatment of malabsorption in cystic fibrosis.
    Mitchell EA; Quested C; Marks RE; Pinnock RE; Elliott RB
    Aust Paediatr J; 1982 Jun; 18(2):114-7. PubMed ID: 6923744
    [No Abstract]   [Full Text] [Related]  

  • 51. New modalities in the treatment of exocrine pancreatic insufficiency in cystic fibrosis.
    Heijerman HG
    Neth J Med; 1992 Oct; 41(3-4):105-9. PubMed ID: 1470278
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The pH-sensitive enteric-coated pancreatic enzyme preparations: an evaluation of therapeutic efficacy in adult patients with pancreatic insufficiency.
    Dutta SK; Tilley DK
    J Clin Gastroenterol; 1983 Feb; 5(1):51-4. PubMed ID: 6551402
    [No Abstract]   [Full Text] [Related]  

  • 53. [Comparison of the enzymatic activity of various pancreatic enzyme preparations in vitro].
    Müller-Wieland K; Berndt W
    Dtsch Med Wochenschr; 1969 Sep; 94(37):1870-2. PubMed ID: 5356320
    [No Abstract]   [Full Text] [Related]  

  • 54. New enteric-coated high-lipase pancreatic extract in the treatment of pancreatic steatorrhea.
    Malesci A; Mariani A; Mezzi G; Bocchia P; Basilico M
    J Clin Gastroenterol; 1994 Jan; 18(1):32-5. PubMed ID: 8113582
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potency of pancreatic enzyme preparations.
    N Engl J Med; 1977 Sep; 297(11):615-6. PubMed ID: 887123
    [No Abstract]   [Full Text] [Related]  

  • 56. Duodenal instillation of pancreatin does not abolish steatorrhea in patients with pancreatic insufficiency.
    Zerega J; Lerner S; Meyer JH
    Dig Dis Sci; 1988 Oct; 33(10):1245-9. PubMed ID: 3168697
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic pancreatitis and persistent steatorrhea: what is the correct dose of enzymes?
    Domínguez-Muñoz JE
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):541-6. PubMed ID: 21377551
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pancreatic enzyme replacement therapy.
    Morrow JD
    Am J Med Sci; 1989 Nov; 298(5):357-9. PubMed ID: 2683774
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine.
    Gow R; Bradbear R; Francis P; Shepherd R
    Lancet; 1981 Nov; 2(8255):1071-4. PubMed ID: 6118524
    [No Abstract]   [Full Text] [Related]  

  • 60. In vitro enzyme activity of commercially available pancreatic enzyme extracts.
    Clain JE; Barbezat GO; Kramer IB; Tigler-Wybrandi NA
    S Afr Med J; 1978 Apr; 53(15):582. PubMed ID: 675423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.